Cost-effectiveness analysis of switching from a bivalent to a nonavalent HPV vaccination programme in China: a modelling studyResearch in context

Summary: Background: Several domestically-manufactured nonavalent HPV vaccine candidates are in phase III clinical trials and their future availability may address the current dilemma of insufficient supply and high price of the overseas-manufactured nonavalent HPV vaccine in China. We compare the...

Full description

Saved in:
Bibliographic Details
Main Authors: Meng Gao, Shangying Hu, Xuelian Zhao, Tingting You, Yuting Hong, Yang Liu, Youlin Qiao, Mark Jit, Fanghui Zhao, Chen Wang
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:The Lancet Regional Health. Western Pacific
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666606525000367
Tags: Add Tag
No Tags, Be the first to tag this record!